Bio-Rad Laboratories Inc

22. aug 2026, 00:02 UTC

Bio Rad Laboratories Inc shares are higher in after-market hours, reflecting a broader market rebound amid gains in major stocks like Tesla and UnitedHealth.

21. aug 2026, 23:21 UTC

Bio Rad Laboratories Inc shares are higher in after-market trading, influenced by Waters Corp's notable increase. Trading remains routine, with Bio Rad above its 20-day moving average.

20. aug 2026, 23:41 UTC

Bio Rad Laboratories Inc shares are higher in after-market trading, recovering from an earlier dip. Declining jobless claims may support broader market sentiment.

19. aug 2026, 20:03 UTC

Shares higher on strength in Life Sciences Tools & Services sector.

18. aug 2026, 20:06 UTC

Bio Rad Laboratories Inc. is lower today, marking four consecutive daily declines. Rising U.S. Treasury yields amid inflation concerns contribute to the broader market context.

14. aug 2026, 19:26 UTC

Bio Rad Laboratories Inc shares are lower today, influenced by disappointing U.S. retail sales data that raised concerns about consumer demand and economic performance.

13. aug 2026, 19:31 UTC

Bio Rad Laboratories Inc shares are declining today, influenced by significant downward movement in the Life Sciences Tools & Services sub-sector.

11. aug 2026, 20:02 UTC

Bio Rad Laboratories Inc is trading higher, maintaining momentum after three consecutive gains. The price remains well above its 20-day moving average.

10. aug 2026, 19:26 UTC

Bio Rad Laboratories Inc shares are lower today, despite earlier gains. No specific news has been identified to explain the decline.

7. aug 2026, 23:56 UTC

Bio Rad Laboratories Inc. shares declined in after-market trading, reflecting routine fluctuations. The stock remains above its 20-day moving average.

6. aug 2026, 20:07 UTC

Bio Rad Laboratories Inc shares are lower today, breaking a recent trend of gains. No specific news was identified to explain this decline.

5. aug 2026, 20:03 UTC

Bio Rad Laboratories shares are higher as RBC raises its price target to $370. Wells Fargo and Citigroup also updated their price targets to $330.

4. aug 2026, 22:02 UTC

Bio-Rad Laboratories shares are lower in after-market trading following a restructuring announcement and lowered full-year sales guidance despite strong second-quarter earnings.

3. aug 2026, 19:46 UTC

Bio Rad Laboratories Inc is trading higher, supported by broader market trends amid falling oil prices. The stock remains near the upper end of its one-month range.

30. juuli 2026, 20:09 UTC

Bio Rad Laboratories shares are trading roughly flat amid mixed economic signals, including lower-than-expected U.S. GDP growth and rising initial jobless claims.

29. juuli 2026, 18:01 UTC

Bio Rad Laboratories Inc shares are lower today, continuing a decline since Tuesday's close. The broader market reacts to rising crude oil prices and inflation concerns.

28. juuli 2026, 17:03 UTC

Bio Rad Laboratories Inc. shares are higher today, diverging from a declining Nikkei 225 Index amid concerns over tech stock sustainability and rising semiconductor production in China.

27. juuli 2026, 19:46 UTC

Bio Rad Laboratories Inc shares are higher today, reaching a session high as crude oil prices decline. No specific company news was identified.

24. juuli 2026, 19:11 UTC

Bio Rad Laboratories Inc shares are lower, impacted by declines in the Life Sciences Tools & Services sub-sector. Earlier, they rebounded from a session low.

23. juuli 2026, 20:03 UTC

Bio Rad Laboratories Inc shares are higher, supported by gains in the Life Sciences Tools & Services sector and positive sentiment from Thermo Fisher Scientific Inc.

22. juuli 2026, 20:07 UTC

Bio Rad Laboratories Inc shares are higher today, maintaining a position above their 20-day moving average and near the upper end of their one-month range.

21. juuli 2026, 16:26 UTC

Bio-Rad Laboratories Inc shares are lower amid negative sentiment surrounding Sartorius, which reported disappointing earnings from Danaher’s bioprocessing unit.

20. juuli 2026, 19:17 UTC

BIO shares lower; iShares U.S. Healthcare ETF declines during session.